Residual risk of HIV, HBV, and HCV transmission through blood transfusion in Borgou, Benin, 2023–2025 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Remaining Risks for HIV, HBV, and HCV Transmission via Blood Transfusion in Borgou, Benin, 2023–2025

  • By

  • Kamel-Dine Djaliri

  • Adolphe Adjanohoun

  • Pamphile Aguessy

  • Victorien Dougnon

  • Haziz Sina

  • Lamine Baba-Moussa

  • June 4, 2026

Share

  • 1

    The study assessed residual risks of HIV, HBV, and HCV transmission via blood transfusion in Borgou, Benin, from 2023 to 2025.

  • 2

    A total of 11,113 repeat donors were analyzed, revealing a male predominance and a majority aged 18–30 years.

  • 3

    Incidence rates per 100,000 donor-years were 5.98 for HIV, 350.28 for HBV, and 77.84 for HCV, with significant associations for HBV and HCV by age.

  • 4

    Estimated residual risks were 1 in 277,000 donations for HIV, 1 in 1,862 for HBV, and 1 in 7,070 for HCV, indicating higher risks than in high-income countries.

  • 5

    The findings emphasize the need for improved donor selection, health education, and advanced screening technologies to enhance blood safety in resource-limited settings.

Original Source(s)

Residual risk of HIV, HBV, and HCV transmission through blood transfusion in Borgou, Benin, 2023–2025

  • by Kamel-Dine Djaliri, Adolphe Adjanohoun, Pamphile Aguessy, Victorien Dougnon, Haziz Sina, Lamine Baba-Moussa

  • June 4, 2026

Related Content

Impact of Viral Infections on Immune Microenvironment Alterations and Responses to Immune Checkpoint Therapy: Interactions Between Infection, Immunity, and Cancer

The Journey to Hepatitis C Elimination in Taiwan: Insights From the Hemodialysis Population

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults